VitriVax

VitriVax is a venture-funded biotechnology startup company, based in Boulder, Colorado, that is revolutionizing how vaccines are distributed and administered globally. Our patented Vaccine Formulation Platform, developed with funding from the National Institutes of Health and the Bill and Melinda Gates Foundation, allows virtually any vaccine to be made thermostable up to 150°F, and enables the combination of prime and boost doses into a single injection, with timed release.